Maxigen Biotech Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	271.02	265.31	190.17	165.83	139.4	87.67
Depreciation & Amortization	34.36	32.03	26.85	27.24	29.05	32.31
Other Amortization	0.11	0.11	0.18	0.37	0.53	0.59
Loss (Gain) From Sale of Assets	-	-	0	-13.62	-1.03	-
Stock-Based Compensation	2.56	3.13	6.69	7.69	13.48	2.45
Provision & Write-off of Bad Debts	-7.32	-7.32	14.47	0.2	4.72	3.02
Other Operating Activities	3.41	5.75	4.78	-5.4	15.37	1.28
Change in Accounts Receivable	-36.8	-31.02	-29.78	-3.8	-12.26	-6
Change in Inventory	-17.28	-23.46	9.45	-9.91	3.68	8.03
Change in Accounts Payable	22.65	36.84	32.87	-18.82	-4.11	7.05
Change in Unearned Revenue	17.89	-7.83	21.6	-2.92	-6.88	7.36
Change in Other Net Operating Assets	4.31	16.69	20.96	24.33	86.38	-26.18
Operating Cash Flow	294.91	290.22	298.22	171.2	268.34	117.59
Operating Cash Flow Growth	-7.41%	-2.68%	74.20%	-36.20%	128.19%	57.71%
Capital Expenditures	-84.07	-81.87	-31.77	-22.44	-14.29	-14.26
Sale of Property, Plant & Equipment	-	-	-	0.9	6.28	-
Sale (Purchase) of Intangibles	-0.77	-0.77	-	-	-0.15	-1.19
Sale (Purchase) of Real Estate	-	-	-	22.59	-	-
Investment in Securities	-300	-300	-	-491.27	16.56	-13.74
Other Investing Activities	11.19	-0.36	2.7	-0.03	2.04	26.41
Investing Cash Flow	-373.64	-382.99	-29.07	-490.25	10.43	-2.78
Short-Term Debt Issued	-	100	-	-	-	-
Total Debt Issued	100	100	-	-	-	-
Long-Term Debt Repaid	-	-	-	-	-0.95	-2.49
Net Debt Issued (Repaid)	100	100	-	-	-0.95	-2.49
Issuance of Common Stock	0.68	0.39	28.69	0.96	-	247.35
Common Dividends Paid	-74.43	-74.43	-88.96	-42.35	-	-56.27
Dividends Paid	-74.43	-74.43	-88.96	-42.35	-	-56.27
Other Financing Activities	0.38	4.7	0.54	-	-0.1	0.1
Financing Cash Flow	26.63	30.66	-59.73	-41.39	-1.05	188.69
Foreign Exchange Rate Adjustments	-1.25	-0.75	-1.45	0.57	-0.08	0.03
Net Cash Flow	-53.35	-62.86	207.97	-359.87	277.64	303.54
Free Cash Flow	210.84	208.36	266.45	148.76	254.05	103.34
Free Cash Flow Growth	-26.65%	-21.80%	79.12%	-41.44%	145.85%	61.91%
Free Cash Flow Margin	25.55%	25.67%	39.15%	23.91%	42.03%	20.18%
Free Cash Flow Per Share	2.35	2.31	2.97	1.66	2.84	1.22
Cash Interest Paid	0.04	0.04	-	-	0.07	0.2
Cash Income Tax Paid	33.83	33.83	30.6	32.72	10.76	8.52
Levered Free Cash Flow	111.59	105.01	186.08	91.4	209.69	71.5
Unlevered Free Cash Flow	111.66	105.03	186.08	91.4	209.73	71.62
Change in Working Capital	-9.23	-8.78	55.09	-11.12	66.81	-9.73

Source: S&P Global Market Intelligence. Standard template. Financial Sources.